{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:59:51Z","timestamp":1786121991998,"version":"build-2736575974"},"reference-count":20,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background\/Objectives: Transfusion-transmitted infections (TTIs) remain an important concern in blood safety. Nucleic acid amplification testing (NAT) shortens the diagnostic window period relative to conventional serological assays. This study aimed to determine the prevalence of Hepatitis B virus(HBV), Hepatitis C virus (HCV), and Human immunodeficiency virus (HIV) among blood donors and to evaluate concordance between NAT and conventional serological screening methods. Methods: A retrospective cross-sectional study was conducted at Riyadh Regional Laboratory from May 2021 to May 2022 and included 48,901 blood donors. Donor samples were tested for HBV, HCV, and HIV using serological assays (chemiluminescent immunoassays on the Abbott Alinity s system) and NAT. Data were analyzed using SPSS. Results: The prevalence of HCV was 0.149% by serological testing and 0.061% by NAT. HBV prevalence was 0.252% by serology and 0.264% by NAT, while HIV prevalence was 0.041% and 0.037%, respectively. NAT identified 25 seronegative but NAT-reactive donations, including 13 HBV, 11 HCV, and 1 HIV donation. A statistically significant difference between NAT and serology was observed for HCV (p &lt; 0.001, McNemar\u2019s test), but not for HBV (p = 0.180) or HIV (p = 0.317). Conclusions: The prevalence of major viral TTIs among blood donors was low, with HBV being the most frequently detected infectious agent. NAT and serological assays provide complementary information and support the continued use of combined screening strategies to enhance transfusion safety.<\/jats:p>","DOI":"10.3390\/jcm15166131","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T08:01:36Z","timestamp":1786089696000},"page":"6131","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of Transfusion-Transmitted Viral Infections Among Blood Donors in Riyadh, Saudi Arabia: A Comparative Analysis of Nucleic Acid Testing and Serological Screening"],"prefix":"10.3390","volume":"15","author":[{"given":"Rana M.","family":"Aldhalaan","sequence":"first","affiliation":[{"name":"College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia"},{"name":"Blood Transfusion Services Center, Health Supported Services Center, Ministry of Health, Riyadh 12382, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6082-3928","authenticated-orcid":false,"given":"Mohammed Raihan","family":"Sajid","sequence":"additional","affiliation":[{"name":"Department of Pathology, College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Layla","family":"Raddaoui","sequence":"additional","affiliation":[{"name":"College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4654-245X","authenticated-orcid":false,"given":"Rimah Abdullah","family":"Saleem","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Medicine, College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nour","family":"Odeh","sequence":"additional","affiliation":[{"name":"College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4175-7520","authenticated-orcid":false,"given":"Rawan","family":"Elshaer","sequence":"additional","affiliation":[{"name":"College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Aldosari","sequence":"additional","affiliation":[{"name":"College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1173-7282","authenticated-orcid":false,"given":"Muhammad Faisal","family":"Ikram","sequence":"additional","affiliation":[{"name":"Department of Anatomy, College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.9734\/IBRR\/2015\/17874","article-title":"Complications of Allogeneic Blood Transfusion: Current Approach to Diagnosis and Management","volume":"3","author":"Adewoyin","year":"2015","journal-title":"Int. Blood Res. Rev."},{"key":"ref_2","unstructured":"World Health Organization (2026, July 01). Blood Safety and Availability. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/blood-safety-and-availability."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1111\/j.1537-2995.2006.00964.x","article-title":"Surveillance of Risk Profiles among New and Repeat Blood Donors with Transfusion-transmissible Infections from 1995 through 2003 in The Netherlands","volume":"46","author":"Coutinho","year":"2006","journal-title":"Transfusion"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/0973-6247.126679","article-title":"Nucleic Acid Testing-Benefits and Constraints","volume":"8","author":"Hans","year":"2014","journal-title":"Asian J. Transfus. Sci."},{"key":"ref_5","unstructured":"World Health Organization (2026, July 01). Hepatitis B. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b."},{"key":"ref_6","unstructured":"World Health Organization (2026, July 01). Hepatitis C. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c."},{"key":"ref_7","unstructured":"World Health Organization (2026, July 01). HIV and AIDS. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-aids."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Wu, D., Feng, F., Wang, X., Wang, D., Hu, Y., Yu, Y., Huang, J., Wang, M., Dong, J., and Wu, Y. (2022). The Impact of Nucleic Acid Testing to Detect Human Immunodeficiency Virus, Hepatitis C Virus, and Hepatitis B Virus Yields from a Single Blood Center in China with 10-Years Review. BMC Infect. Dis., 22.","DOI":"10.1186\/s12879-022-07279-5"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1111\/j.1537-2995.2009.02212.x","article-title":"Experience of Mandatory Nucleic Acid Test (NAT) Screening across All Blood Organizations in Germany: NAT Yield versus Breakthrough Transmissions","volume":"49","author":"Heiden","year":"2009","journal-title":"Transfusion"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/vox.13592","article-title":"International Review of Blood Donation Nucleic Acid Amplification Testing","volume":"119","author":"Faddy","year":"2024","journal-title":"Vox Sang."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Tessema, B., Yismaw, G., Kassu, A., Amsalu, A., Mulu, A., Emmrich, F., and Sack, U. (2010). Seroprevalence of HIV, HBV, HCV and Syphilis Infections among Blood Donors at Gondar University Teaching Hospital, Northwest Ethiopia: Declining Trends over a Period of Five Years. BMC Infect. Dis., 10.","DOI":"10.1186\/1471-2334-10-111"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Yang, S., Jiao, D., Liu, C., Lv, M., Li, S., Chen, Z., Deng, Y., Zhao, Y., and Li, J. (2016). Seroprevalence of Human Immunodeficiency Virus, Hepatitis B and C Viruses, and Treponema Pallidum Infections among Blood Donors at Shiyan, Central China. BMC Infect. Dis., 16.","DOI":"10.1186\/s12879-016-1845-z"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40249-017-0255-9","article-title":"Seroprevalence of Hepatitis B, Hepatitis C, Human Immunodeficiency Virus, Treponema Pallidum, and Co-Infections among Blood Donors in Kyrgyzstan: A Retrospective Analysis (2013\u20132015)","volume":"6","author":"Karabaev","year":"2017","journal-title":"Infect. Dis. Poverty"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s00580-013-1751-3","article-title":"Donor Minipool NAT Screening for HBV, HCV, and HIV: A 2-Year Experience in a Private Hospital in Saudi Arabia","volume":"23","author":"Selim","year":"2014","journal-title":"Comp. Clin. Pathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.15537\/smj.2022.43.12.20220634","article-title":"Prevalence of Transfusion-Transmitted Infections in Saudi Arabia Blood Donors: A Nationwide, Cross-Sectional Study","volume":"43","author":"Alsughayyir","year":"2022","journal-title":"Saudi Med. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s44197-022-00051-7","article-title":"Patterns of Hepatitis B, Hepatitis C and HIV Among Blood Donors in Samtah-Jazan Region","volume":"12","author":"Mobarki","year":"2022","journal-title":"J. Epidemiol. Glob. Health"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Badawi, M.A., Eldakhakhny, S., Ali, M., Badawi, M., Khiariy, J., Bin-Taleb, Y., and Hindawi, S.I. (2025). Key Challenges in Screening Blood Donors for Hepatitis B Virus. Viruses, 18.","DOI":"10.3390\/v18010023"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Tounsi, W.A. (2025). Prevalence and Implications of Occult Hepatitis B Virus Infection Among Blood Donors in Saudi Arabia: A Systematic Review and Meta-Analysis. Diagnostics, 15.","DOI":"10.3390\/diagnostics15233004"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2147\/IDR.S270355","article-title":"HIV in the Kingdom of Saudi Arabia: Can We Change the Way We Deal with Co-Infections","volume":"14","author":"Alrahbeni","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e70117","DOI":"10.1002\/rmv.70117","article-title":"Improved Safety of Nucleic Acid Amplification Technology Combined with Serological Tests for Screening Blood Donors: A Systematic Review and Meta-Analysis","volume":"36","author":"Madeira","year":"2026","journal-title":"Rev. Med. Virol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/16\/6131\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T08:24:56Z","timestamp":1786091096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/16\/6131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":20,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["jcm15166131"],"URL":"https:\/\/doi.org\/10.3390\/jcm15166131","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]}}}